Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany. by Florian Schwarz, Habibollah Arefian, Michael Hartmann, Ingo Runnebaum

Get full text

Comparative cost-effectiveness of cabozantinib as second-line therapy for patients with advanced hepatocellular carcinoma in Germany and the United States by Maximilian Sieg, Michael Hartmann, Utz Settmacher, Habibollah Arefian

Get full text

Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany. by Florian Schwarz, Habibollah Arefian, Michael Hartmann, Ingo Runnebaum

Get full text

Economic Evaluation of Interventions for Prevention of Hospital Acquired Infections: A Systematic Review. by Habibollah Arefian, Monique Vogel, Anja Kwetkat, Michael Hartmann

Get full text

Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany by Florian Schwarz, Habibollah Arefian, Michael Hartmann, Ingo Runnebaum

Get full text

Cost-effectiveness of allergic rhinitis treatment: An exploratory study by Jan Titulaer, Habibollah Arefian, Michael Hartmann, Mustafa Z Younis, Orlando Guntinas-Lichius

Get full text

Estimating extra length of stay due to healthcare-associated infections before and after implementation of a hospital-wide infection control program. by Habibollah Arefian, Stefan Hagel, Dagmar Fischer, André Scherag, Frank Martin Brunkhorst, Jens Maschmann, Michael Hartmann

Get full text